MedTrace Logo

The Effects of Increased Central Serotonergic Activity on Information Processing

NCT00206934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-09-19

No results posted yet for this study

Summary

It is of great clinical relevance to know if selective serotonin re-uptake inhibitors affect information processing. Our hypothesis was that aspects of information processing would be disturbed whereas others would improve.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Escitalopram

Either 10 mg of escitalopram or placebo will be administered to a group of healthy volunteers

DRUG

escitaolpram

Either 15 mg of escitalopram or placebo will be administered to healthy volunteers

Sponsors & Collaborators

  • Lundbeck Foundation

    collaborator OTHER

  • Glostrup University Hospital, Copenhagen

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Birte Glenthoj, MD, DMSc. · Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychaitric Center Glostrup, Ndr. Ringvej, DK-2600 Glostrup, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2006-03-31
Completion
2006-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00206934 on ClinicalTrials.gov